Antimicrobial resistance / Projects

First Programme of Community action in the field of public health (2003-2008)
Improving Patient Safety in Europe [IPSE]
The main objectives of IPSE are to: (a) establish a consensus Infection Control Professional core curriculum and inventory of courses, (b) produce deliverables providing managers and health services s...
The main objectives of IPSE are to: (a) establish a consensus Infection Control Professional core curriculum and inventory of courses, (b) produce deliverables providing managers and health services staff with timely and periodic information and indicators of the morbidity of HAI, (c) make available evidence-based guidelines and educational tools to better and effectively manage the risk of HAI and AMR. Early detection and response to nosocomial outbreaks of known or new pathogens, including multiple resistant organisms should progress (2002/77/EC). The project is intended to foster the containment of the emergence and spread of multiple resistant organisms in the ICU through an integrated surveillance programme and provide educational support to new HAI surveillance networks. Finally a consensus on surveillance of healthcare-associated infections in EU nursing homes is necessary.
Start date: 01/01/2005 - End date: 01/01/2008
Call: Health Threats (Ht 2004)
Topic: Antimicrobial resistance
First Programme of Community action in the field of public health (2003-2008)
Burden of Disease and Resistance in European Nations [-]
To provide realistic estimates of the burden of disease and the costs attributable to infections caused by antimicrobial resistant pathogens in Member States and Accession Countries of the European Un...
To provide realistic estimates of the burden of disease and the costs attributable to infections caused by antimicrobial resistant pathogens in Member States and Accession Countries of the European Union. The strategic goals pursued in the general objective are: - To provide valid data for politicians, policy-makers and public health experts that will allow informed estimates of the burden and the costs of AMR on a national level - To allow a comparison of costs between countries of the European Region. - Recommendations for participating countries/hospitals for implantation effective measures to keep costs caused by AMR to a minimum. - To inform public health authorities throughout Europe, in order to prioritise and plan future health political goals, as against other specific causes of morbidity and mortality in Europe
Start date: 01/01/2007 - End date: 01/01/2010
Call: Health Threats (Ht 2005)
Topic: Antimicrobial resistance
3rd Health Programme (2014-2020)
ERN Rare Craniofacial Anomalies and ENT Disorders [CRANIO]
This proposal lays out the Work Programme for 2017 within the contents of the Multiannual Work Plan for the European Reference Network for Craniofacial Anomalies and ENT disorders (ERN CRANIO). ERN CR...
This proposal lays out the Work Programme for 2017 within the contents of the Multiannual Work Plan for the European Reference Network for Craniofacial Anomalies and ENT disorders (ERN CRANIO). ERN CRANIO involves teams from 29 European hospitals (10 Member States) that provide care, education, teaching, research and management of rare craniofacial anomalies, cleft lip/palate and ENT disorders. Our vision is that the best multidisciplinary initial care for all those with craniofacial anomalies and ENT disorders is not a privilege to be purchased but a moral right secured for all European patients.
Our MISSION is to consistently and persistently strive towards achieving our vision through:
1. Establishment and management of a steady referral network for patients with craniofacial anomalies and ENT disorders throughout Europe; 2. Improvement of the quality of care, by enhancing diagnosis, treatment and follow-up of the patients with rare craniofacial anomalies and ENT disorders; 3. Minimization of the deviation from our operational standards and sharing best practices through suitable quality improvement initiatives, while monitoring their effectiveness using measures and indicators; 4. Stimulating innovation through multicentre research projects on (genetic) causes, pathophysiology, and associated problems, and introduction of eHealth; 5. Supporting the continuous learning and development of all our members by providing high quality educational and training opportunities to medical, nursing and other healthcare professionals; 6. Disseminating gained knowledge, making it available to all stakeholders.

In Year 1, ERN CRANIO will focus on collecting and analysing the available data on diagnoses, treatment, follow-up programmes, education and eHealth. In addition, the aim is to further expand the network in the first year by including relevant partners and experts. The results of the first year will set the agenda for subsequent years.
Start date: 01/03/2017 - End date: 28/02/2018

Call: EUROPEAN REFERENCE NETWORKS SPECIFIC GRANT AGREEMENTS COVERING YEAR 2017
Topic: Antimicrobial resistance
First Programme of Community action in the field of public health (2003-2008)
European Committee on Antimicrobial Susceptibility Testing [EUCAST]
Antimicrobial susceptibility testing of bacteria and fungi and antimicrobial resistance surveillance are closely linked together. The latter is heavily dependant on the former. There is an urgent need...
Antimicrobial susceptibility testing of bacteria and fungi and antimicrobial resistance surveillance are closely linked together. The latter is heavily dependant on the former. There is an urgent need for European standardization and harmonization of breakpoints and reference methodology for antimicrobial susceptibility testing. Project vision: In accordance with the council recommendations 2002/77/EC, to create a pan-European network (the EUCAST General Committee) and a European standing committee (EUCAST Steering committee) with the objectives to harmonize European clinical MIC breakpoints for antibacterial and antifungal drugs and to define epidemiological cut-off values for the early detection and measurement and international comparison of antimicrobial resistance development. Furthermore, to create an interactive web-based system for the collection of MIC-values and the display of reference wild type distributions of MIC-values to be used for methodological standardization and for breakpoint setting; to offer liaison with and expertise to European dedicated surveillance networks and European regulatory bodies, and to take initiatives within education in the respective fields.
Start date: 01/05/2004 - End date: 01/05/2007
Call: Health Threats (Ht 2003)
Topic: Antimicrobial resistance
First Programme of Community action in the field of public health (2003-2008)
European Antimicrobial Resistance Surveillance System [EARSS]
EARSS collects and provides information on the prevalence and spread of invasive pathogens with clinically and epidemiologically relevant antimicrobial resistance for public health initiatives. Taking...
EARSS collects and provides information on the prevalence and spread of invasive pathogens with clinically and epidemiologically relevant antimicrobial resistance for public health initiatives. Taking into account laboratory methods as well as denominator data, EARSS monitors variation in antimicrobial resistance over time and place and aims to disseminate timely information on the emergence of bacterial clones of particular public health importance in terms of epidemic potential and resistance. The EARSS network and database shall provide the basis for policy decisions as well as rapid response and may be used to assess the effectiveness of interventions. EARSS gives interactive electronic feedback, provides basic data to stimulate specific studies and assesses the role of antibiotic consumption and other risk factors in partnership with ESAC and other DG SANCO funded networks, with the aim to facilitate guidelines for antibiotic usage.
Start date: 01/09/2003 - End date: 01/09/2006
Call: Health Threats (Ht 2003)
Topic: Antimicrobial resistance